Volume 10, Issue 1 (6-2023)                   NBR 2023, 10(1): 1-10 | Back to browse issues page

XML Persian Abstract Print

Department of Animal Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran , attari@ut.ac.ir
Abstract:   (476 Views)
Breast cancer is the most common cause of death from cancer among women. The triple-negative breast cancer (TNBC) is the most invasive subtype, and chemotherapy is the only therapy option. Cancer cells preferably utilize the glycolysis pathway even with proper oxygen availability, and this activation plays a great role in tumorigenesis. Therefore, glycolysis targeting can be an effective strategy for cancer treatment. Here, the apoptotic effect of a glycolysis inhibitor named dichloroacetate (DCA) on TNBC cells MDA-MB-231 was assessed, and the expression of anti-apoptotic genes and oncogenic miRNAs was evaluated. MTT assay showed that DCA reduces cell viability in a dose-dependent manner with the IC50 concentration of 50 mM. Annexin/PI assay demonstrated that DCA due to DCA treatment. Finally, the expression of anti-apoptotic genes Bcl2l1 and Mcl1 and oncogenic miRNAs miR21 and miR27a decreased due to DCA treatment. Our results confirmed that DCA, as a glycolysis inhibitor, leads to apoptosis induction in TNBC cells because of reducing expression of viability genes and miRNAs.
Full-Text [PDF 563 kb]   (328 Downloads)    
Type of Study: Original Article | Subject: Cell and Molecular Biology
Received: 2022/12/8 | Revised: 2023/06/26 | Accepted: 2023/01/21 | Published: 2023/06/20 | ePublished: 2023/06/20

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.